Jodoigne, Belgium

Patrick Chaltin

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Jodoigne, BE (2013 - 2016)
  • Zétrud-Lumay, BE (2016 - 2018)
  • Zetrud-Lumay, BE (2014 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Chaltin

Introduction

Patrick Chaltin is a notable inventor based in Jodoigne, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating various disorders. With a total of 13 patents to his name, Chaltin's work has the potential to impact the treatment of pain and inflammatory hypersensitivity.

Latest Patents

Among his latest patents, Chaltin has developed heterocycle derivatives aimed at treating TRPM3 mediated disorders. These compounds are particularly useful for the prevention or treatment of conditions related to pain and inflammatory hypersensitivity. His innovative approach includes methods for effectively addressing these disorders, showcasing his commitment to advancing medical science.

Career Highlights

Chaltin has had a distinguished career, working with prestigious institutions such as Katholieke Universiteit Leuven and its research and development arm, KU Leuven R&D. His work in these organizations has allowed him to collaborate with other experts in the field, further enhancing his contributions to medicinal chemistry.

Collaborations

Throughout his career, Chaltin has collaborated with notable colleagues, including Arnaud Marchand and Amuri Kilonda. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective research areas.

Conclusion

Patrick Chaltin's innovative work in developing compounds for treating TRPM3 mediated disorders highlights his significant contributions to medicinal chemistry. His patents and collaborations reflect a dedication to improving healthcare outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…